YU6999A - Farmaceutski aerosolni preparat - Google Patents

Farmaceutski aerosolni preparat

Info

Publication number
YU6999A
YU6999A YU6999A YU6999A YU6999A YU 6999 A YU6999 A YU 6999A YU 6999 A YU6999 A YU 6999A YU 6999 A YU6999 A YU 6999A YU 6999 A YU6999 A YU 6999A
Authority
YU
Yugoslavia
Prior art keywords
mmad
aerosol
inhaler
aerosol composition
pharmaceutical aerosol
Prior art date
Application number
YU6999A
Other languages
English (en)
Inventor
David Lewis
Davis Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU6999(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of YU6999A publication Critical patent/YU6999A/sh
Publication of RS51274B publication Critical patent/RS51274B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Preparat za korišćenje u aerosolnom inhaleru koji obuhvata aktivnu materiju, propelant koji sadrži hidrofluoroalkan (HFA) i ko-rastvarač. Preparat dalje obuhvata nisko isparljivu komponentu radi povećanja masenog prosečnog aerodinamičkog prečnika (MMAD) aerosolnih čestica pri aktiviranju (pokretanju) inhalera. Sa dodatkom nisko isparljive komponente, MMAD aerosolnih čestica može da bude uporedivo sa MMAD aerosolnih čestica aerosolnog inhalera koji sadrži CFC ka propelant.
YUP-69/99A 1997-06-13 1998-06-10 Farmaceutski aerosolni preparat RS51274B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (2)

Publication Number Publication Date
YU6999A true YU6999A (sh) 2000-03-21
RS51274B RS51274B (sr) 2010-12-31

Family

ID=10814179

Country Status (45)

Country Link
EP (2) EP0920302B2 (sh)
JP (1) JP4380802B2 (sh)
KR (1) KR100546239B1 (sh)
CN (1) CN1138532C (sh)
AR (1) AR012977A1 (sh)
AT (1) ATE222751T1 (sh)
AU (1) AU729966B2 (sh)
BG (1) BG63906B1 (sh)
BR (1) BR9805993B1 (sh)
CA (1) CA2263445C (sh)
CO (1) CO4940408A1 (sh)
CZ (1) CZ295521B6 (sh)
DE (1) DE69807420T3 (sh)
DK (1) DK0920302T4 (sh)
DZ (1) DZ2516A1 (sh)
EA (1) EA001259B1 (sh)
EE (1) EE03664B1 (sh)
ES (1) ES2182351T5 (sh)
GB (1) GB2326334A (sh)
GE (1) GEP20012462B (sh)
HK (1) HK1022271A1 (sh)
HR (1) HRP980317B1 (sh)
HU (1) HU228487B1 (sh)
ID (1) ID21491A (sh)
IL (1) IL128484A (sh)
IN (1) IN189317B (sh)
IS (1) IS2435B (sh)
IT (1) IT1293803B1 (sh)
MA (1) MA26507A1 (sh)
ME (2) MEP44008A (sh)
MY (1) MY119074A (sh)
NO (1) NO327775B1 (sh)
NZ (1) NZ334149A (sh)
PL (1) PL193721B1 (sh)
PT (1) PT920302E (sh)
RS (1) RS51274B (sh)
SA (1) SA98190821B1 (sh)
SI (1) SI0920302T2 (sh)
SK (1) SK284430B6 (sh)
TN (1) TNSN98087A1 (sh)
TR (1) TR199900288T1 (sh)
TW (1) TW555570B (sh)
UA (1) UA70289C2 (sh)
WO (1) WO1998056349A1 (sh)
ZA (1) ZA985136B (sh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
EP1143930B8 (en) 1999-09-11 2008-03-19 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
JP2003514841A (ja) * 1999-11-23 2003-04-22 グラクソ グループ リミテッド サルメテロールの医薬製剤
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CZ303833B6 (cs) 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
MXPA04008372A (es) 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
ES2275778T3 (es) * 2002-06-06 2007-06-16 Chiesi Farmaceutici S.P.A. Solubilizacion de farmacos en propulsores de hfa mediante emulsiones.
WO2004071488A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
RS51663B (en) * 2003-03-20 2011-10-31 Boehringer Ingelheim Pharmaceuticals Inc. DOSAGE FORMULATION INHALATOR USING HYDRO-FLUORO-ALKAN AS PROPELLENT
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
JP5209963B2 (ja) 2004-07-02 2013-06-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 噴霧剤としてｔｇ２２７ｅａ又はｔｇ１３４ａを含有するエアロゾル懸濁製剤
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
KR20100095437A (ko) * 2007-11-07 2010-08-30 아스트라제네카 아베 아스코르브산 유도체를 포함하는 건조 분말 제제
CN103079619B (zh) * 2010-09-06 2017-03-01 奇斯药制品公司 计量剂量吸入器和使用该计量剂量吸入器的方法
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
EP2819669B1 (de) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (fr) 2016-03-31 2021-04-28 Chiesi Farm Spa Dispositif d'inhalation d'aérosol
ES2841649T5 (es) * 2016-09-19 2024-04-24 Mexichem Fluor Sa De Cv Composición farmacéutica

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863720A (en) † 1986-03-10 1989-09-05 Walter Burghart Pharmaceutical preparation and methods for its production
AU597049B2 (en) † 1986-03-10 1990-05-24 Kurt Burghart Pharmaceutical preparation containing nifedipine
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DE69105212T2 (de) † 1990-10-18 1995-03-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
NZ243061A (en) † 1991-06-10 1993-09-27 Schering Corp Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane
US6503482B1 (en) † 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
DE69218455T2 (de) * 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
WO1995031182A1 (en) † 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
IES80485B2 (en) † 1996-12-04 1998-08-12 Bioglan Ireland R & D Ltd Pharmaceutical compositions and devices for their administration
AU718967B2 (en) † 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations

Also Published As

Publication number Publication date
AU729966B2 (en) 2001-02-15
AU8626298A (en) 1998-12-30
GB9712434D0 (en) 1997-08-13
IL128484A0 (en) 2000-01-31
BG103221A (en) 1999-09-30
EP0920302A1 (en) 1999-06-09
DK0920302T3 (da) 2002-12-23
DK0920302T4 (da) 2006-10-09
IL128484A (en) 2004-09-27
HUP0001339A2 (hu) 2000-09-28
HUP0001339A3 (en) 2000-10-30
ZA985136B (en) 1999-01-07
KR100546239B1 (ko) 2006-01-26
MA26507A1 (fr) 2004-12-20
WO1998056349A1 (en) 1998-12-17
ME00333B (me) 2011-02-10
EP0920302B2 (en) 2006-06-21
CZ295521B6 (cs) 2005-08-17
SK17699A3 (en) 1999-07-12
BR9805993A (pt) 1999-08-31
AR012977A1 (es) 2000-11-22
SI0920302T2 (sl) 2006-10-31
ES2182351T3 (es) 2003-03-01
DE69807420T3 (de) 2006-11-16
EP0920302B1 (en) 2002-08-28
DE69807420T2 (de) 2003-05-08
GB2326334A (en) 1998-12-23
DE69807420D1 (de) 2002-10-02
CO4940408A1 (es) 2000-07-24
ITMI971798A1 (it) 1999-01-28
TW555570B (en) 2003-10-01
PT920302E (pt) 2002-11-29
IS2435B (is) 2008-10-15
EE03664B1 (et) 2002-04-15
SK284430B6 (sk) 2005-04-01
SA98190821B1 (ar) 2006-11-19
KR20000068171A (ko) 2000-11-25
EP1219293A3 (en) 2003-05-28
NO990594D0 (no) 1999-02-09
TNSN98087A1 (fr) 2005-03-15
HU228487B1 (en) 2013-03-28
CA2263445A1 (en) 1998-12-17
JP4380802B2 (ja) 2009-12-09
SI0920302T1 (en) 2002-12-31
DZ2516A1 (fr) 2004-11-08
EA199900201A1 (ru) 1999-06-24
IS4974A (is) 1999-02-11
ES2182351T5 (es) 2007-03-16
EP1219293A2 (en) 2002-07-03
NZ334149A (en) 2000-07-28
PL193721B1 (pl) 2007-03-30
MEP44008A (en) 2011-02-10
HRP980317B1 (en) 2002-06-30
ID21491A (id) 1999-06-17
TR199900288T1 (xx) 1999-09-21
IN189317B (sh) 2003-02-08
EA001259B1 (ru) 2000-12-25
MY119074A (en) 2005-03-31
CZ46299A3 (cs) 1999-07-14
EE9900055A (et) 1999-08-16
PL331531A1 (en) 1999-07-19
NO327775B1 (no) 2009-09-21
BG63906B1 (bg) 2003-06-30
BR9805993B1 (pt) 2009-05-05
NO990594L (no) 1999-04-13
CA2263445C (en) 2008-09-09
CN1229355A (zh) 1999-09-22
CN1138532C (zh) 2004-02-18
HK1022271A1 (en) 2000-08-04
HRP980317A2 (en) 1999-04-30
RS51274B (sr) 2010-12-31
ATE222751T1 (de) 2002-09-15
GEP20012462B (en) 2001-06-25
JP2000516965A (ja) 2000-12-19
UA70289C2 (uk) 2004-10-15
IT1293803B1 (it) 1999-03-10

Similar Documents

Publication Publication Date Title
YU6999A (sh) Farmaceutski aerosolni preparat
RS49907B (sr) Koncentrat delotvorne supstance sa formoterolom koji je duže upotrebljiv
EP1787639A3 (en) Stable pharmaceutical solution formulations for pressurised metered dose inhalers
RS49977B (sr) Farmaceutske formulacije za aerosolove sa dve ili više aktivnih supstanci
BR9909394A (pt) Composição de aerossol, composição farmacêutica, recipiente, dispositivo de inalação, processo para preparar uma composição de aerossol, mistura de um primeiro material particulado, e, processo para administrar um medicamento particulado
PT731688E (pt) Formulacoes de farmacos em aerossol para utilizacao com propulsores sem cfc
DE69231992D1 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
GEP20063985B (en) Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
ES2064160T3 (es) Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
BR0108584A (pt) Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva
IT1303788B1 (it) Formulazioni di aerosol medicinali.
DK1244487T3 (da) Aerosolinhalator
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
EP2612703A3 (en) Particulate materials
EP1110547A3 (en) Helium and neon as means delivering drug in inhaler
MX9707073A (es) Preparaciones de aerosol de prilocaina e hidrofluorocarbono.